Applications

Clinical PET is one of the key medical imaging modalities for diagnosis, staging and treatment evaluation in oncology, neurology, cardiology, and immunology.

Preclinical PET has become a core biomedical research tool providing the means to image small laboratory animals while serving as a bridge to understanding human disease models.

The power of PET is growing— what discipline or biologically relevant end points are you interested in?

ONCOLOGY

[18F]FDG PET is a common assay of glycolysis for use in oncology. Thanks to its high sensitivity, GENISYS4 can detect changes in tumor glycolysis with [18F]FDG to differentiate malignant tissue from necrosis and edema.

Measuring Drug Resistance

CELL THERAPY

Gene and cell-based therapies are creating
new opportunities in oncology research.
Scientists are able to use PET, along with
optical techniques, for in vivo detection of
reporter gene-labelled transplanted cells.








CARDIOLOGY

[18F]FDG PET can provide important insights into the physiology and biology of the heart and enable researchers to explore the effects of new therapeutics.


BIODISTRIBUTION

GENISYS4 is capable of performing dynamic studies to measure the kinetics of transport and metabolism. In the end, it’s not just about images, but about quantitative measurements of kinetics.